US2020214889A1PendingUtilityA1

Intraocular delivery devices and methods therefor

Assignee: OCUJECT LLCPriority: Apr 2, 2012Filed: Jan 6, 2020Published: Jul 9, 2020
Est. expiryApr 2, 2032(~5.7 yrs left)· nominal 20-yr term from priority
A61M 5/46A61M 5/3243A61F 9/00736A61M 5/38A61M 2210/0612A61F 9/0026A61M 5/3145A61F 9/0017
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Injection devices for delivering pharmaceutical compositions into the eye are described. Some devices include a resistance component for controllably deploying an injection needle through the eye wall. The resistance component may be disposed on a removable injector attachment or on a portion of the injection device housing. Other devices may include a filter for the removal of air, infectious agents, and/or other particulate matter from the composition before the composition of air, infectious agents, and/or other particulate matter from the composition before the composition is injected into the eye. Related methods and systems comprising the devices are also described.

Claims

exact text as granted — not AI-modified
1 - 41 . (canceled) 
     
     
         42 . A needle assembly, comprising:
 a needle hub having a tubular body and comprising an input port on its proximal end for removable connection to an injector having a drug reservoir, and a distal stop surface;   a needle having a proximal portion and a distal portion, the proximal portion of the needle housed within the tubular body of the needle hub, and the distal end of the needle extending distally beyond the needle hub;   a slidable shield operatively coupled to the needle hub, the slidable shield configured for axial movement along the needle hub between the input port and the stop surface and configured such that the needle is completely circumscribed by the shield when the shield is in a first, distal position with respect to the needle hub, and the distal portion of the needle extends distally beyond the shield when the shield is in a second, proximal position with respect to the needle hub;   an atraumatic ocular contact surface configured to be atraumatic to the conjunctiva or corneal surfaces, the ocular contact surface having a perimeter and coupled to the distal end of the slidable shield; and   a resistance component attached to the tubular body of the needle hub, the resistance component configured to reversibly prevent axial movement of the slidable shield and to maintain the shield in the first, proximal position with respect to the needle hub.

Join the waitlist — get patent alerts

Track US2020214889A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.